MedTrace Logo

Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain

NCT07615816 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2026-05-29

No results posted yet for this study

Summary

The goal of this clinical trial is to determine if a weekly regimen of Medical Massage Therapy (MMT) with provider-directed care shortens the duration of Medically Restricted Duty Days (MRDD) periods in Active-Duty Service Members with Subacute Lower Back Pain (LBP) compared to provider-directed care alone.

The main question the study aims to answer is, when used as an adjunct to provider-directed care, a consistent program of MMT provided by a qualified practitioner, will shorten the duration of MRDD periods, reduce pain, and decrease unnecessary healthcare utilization in patients with Subacute LBP compared to provider-directed care alone. Researchers will study this hypothesis through the comparison of Group #1 (provider-directed care alone) and Group #2 (provider-directed care and MMT).

Participants randomized into the two study groups will be following a 12-week study design (+/- 2 weeks) comprised of their compliance to their provider-directed care, the study intervention (if randomized to Group #2) and study case report forms (CRFs); with a final follow up visit (up to 4 weeks following their final treatment visit).

Conditions

  • Lower Back Pain
  • Subacute Lower Back Pain
  • Medical Massage Therapy

Interventions

PROCEDURE

Medical Massage Therapy

Massage and educational treatment provided by a licensed massage therapist.

OTHER

Provider Directed Care

Provider directed care (i.e. Physical Therapy)

Sponsors & Collaborators

  • Uniformed Services University of the Health Sciences

    collaborator FED

  • Madigan Army Medical Center

    collaborator FED

  • The Geneva Foundation

    lead OTHER

Principal Investigators

  • Ghena G. Grinshpun, PhD, MBA, MSF, PMP · Madigan Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07615816 on ClinicalTrials.gov